Amlodipine Besylate
Product Images NDC 10135-524
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 10135-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine Besylate versus Placebo)
Figure 2 – Effects On Primary Endpoint Of Amlodipine Besylate Versus Placebo Across Sub- Groups (Amlodipine Besylate Tablet 03)
Marlexamlodipine Besylate Tablets2.5 mg*rx Only500 Tablets (Amlodipine Besylate Tablet 04)
Marlexamlodipine Besylate Tablets5 mg*rx Only500 Tablets (Amlodipine Besylate Tablet 05)
Marlexamlodipine Besylate Tablets10 mg*rx Only1000 Tablets (Amlodipine Besylate Tablet 06)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.